Divi's Laboratories Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1990

Chairman: Murali K Divi

Managing Director: Murali K Divi

Group: Divis Labs

Listing: NSE: DIVISLAB, BSE: 532488

Headquarters: Hyderabad, Telangana

Website: www.divislaboratories.com

Key Facts

Market cap: R 50,760.25 Cr

Revenue (TTM): R 5,143.19 Cr

Earnings (TTM): R 1,289.02 Cr

Cash: R 1,513.60 Cr

Total Debt: R 105.60 Cr

Promoters' ownership: 52.00%

Liquidity: High

52 Week range: R 1,460.10 - 1,926.40

Face value: R2.00

Shares outstanding: 26,54,68,580

Stock Performance

Trailing
Annual

Time Period	Divi's Laboratories	S&P BSE Sensex*	S&P BSE Healthcare*
YTD	3.51	0.32	5.04
1 month	5.15	-0.62	5.36
3 months	8.30	5.96	9.68
1 Year	27.94	14.62	0.28
3 Years	40.90	15.13	-1.51
5 Years	17.86	7.16	-1.88
10 Years	19.84	9.39	11.24

As on 24-Jan-2020 *As on 23-Jan-2020

Year	Divi's Laboratories	S&P BSE Sensex	S&P BSE Healthcare
2019	25.10	14.38	-3.55
2018	34.77	5.87	-5.89
2017	40.15	27.91	0.49
2016	-32.58	1.95	-12.88
2015	32.33	-5.03	15.06
2014	40.44	29.89	47.43
2013	11.21	8.98	22.55

Annual Report (FY18)

Review & Analysis

Value your funds
Kumar Shankar Roy . 29-Jan-2018
Premium pharma player: Divis Labs
Yash Rohra . 21-Dec-2017
How to spot current performers
Mohammed Ekramul Haque . 22-Feb-2016
The quest for value
Mohammed Ekramul Haque . 20-Oct-2015
The Money-maker
Mohammed Ekramul Haque . 06-May-2015

News & Announcements